Ligand Partners’ Second Generation SERMs

Product

Partner

Indication

Status

·

Lasofoxifene

Pfizer

Osteoporosis

Phase III

·

TSE-424

AHP

Osteoporosis

Phase III

·

ERA-923

AHP

Breast Cancer

Phase III

·

TSE-424 +

PREMARIN®

AHP

HRT

Phase II

Previous slide

Next slide

Back to first slide

View graphic version